Logo-bi
Original Research

1. Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period

Nadezhda V. Maksimova ORCID, Anna V. Michenko, Olga A. Krasilnikova ORCID, Ilya D. Klabukov* ORCID, Igor Yu. Gadaev ORCID, Michael E. Krasheninnikov ORCID, Pavel A. Belkov, Aleksey V. Lyundup ORCID
Bioimpacts. 2022;12(1): 51-55. doi: 10.34172/bi.2021.22167
PMCID: PMC8783077     PMID: 35087716     Scopus ID: 85127152579    
Article
PDF
Full Text
XML
Cited By:
13
7
6
Three-year follow-up of patients, treated for diabetic foot ulcers with mesenchymal stromal cells that revealed absence of ulcer recurrence, neoplasms, and scar contracture. Collagen ultrasound density decreased by 57% and the epidermal thickness increased by 72% in the area of healed ulcers.
Original Article

2. Preparation and evaluation of a polycaprolactone/chitosan/propolis fibrous nanocomposite scaffold as a tissue engineering skin substitute
Seyedeh-Sara Hashemi ORCID, Ali Akbar Mohammadi ORCID, Seyedeh-Somayeh Rajabi, Parisa Sanati ORCID, Alireza Rafati ORCID, Mehdi Kian* ORCID, Zahra Zarei* ORCID
Bioimpacts. 2023;13(4): 275-287. doi: 10.34172/bi.2023.26317
PMCID: PMC10460768     PMID: 37645024     Scopus ID: 85168111465    
Article
PDF
Full Text
XML
Cited By:
6
0
1
An overview of the fabrication process of the polycaprolactone/chitosan/propolis scaffold followed by the characterization of physical, chemical, and biological properties as a proper candidate for dressing skinwounds.

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge